Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STM vs MRNA✓SelectedUSD · MRNASTM vs MRNA performance historyLatest closeAs of+0.58%11/13
Stock and ETF performance explorer

STM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+98.3%
MRNA return
+755.5%
Excess return
-657.2%
Maximum drawdown
-49.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.6%-3.4%+4.0%+0.6%
7D+12.0%-12.1%+24.1%+12.2%
30D-0.4%-1.3%+0.9%-0.3%
3M-13.2%+250.9%-264.1%-13.6%
6M-26.1%+343.0%-369.1%-31.2%
YTD+81.2%+657.4%-576.3%+45.5%
1Y+98.3%+794.9%-696.6%+46.1%
All+98.3%+755.5%-657.2%+46.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling